Acute inflammation in young children inhibits C-type natriuretic peptide

Timothy C R Prickett1, James Hector-Taylor, Robert C Olney

  • 1Department of Medicine, University of Otago, Christchurch, New Zealand. tim.prickett@otago.ac.nz

Pediatric Research
|June 5, 2013
PubMed

Insights

Acute illness in children significantly reduces C-type natriuretic peptide (CNP) levels, impacting growth velocity. This finding is crucial for assessing growth disorders in pediatric patients.

Area of Science:

  • Pediatric Endocrinology
  • Biochemistry
  • Inflammation Research

Background:

  • C-type natriuretic peptide (CNP) is a key paracrine growth factor in endochondral bone development.
  • Amino-terminal CNP (NTproCNP) in plasma reflects growth-plate activity and pediatric growth velocity.
  • Adult inflammation elevates CNP; pediatric acute illness effects were unexplored.

Purpose of the Study:

  • To investigate the relationship between acute illness, inflammation markers, and CNP peptide levels in young children.
  • To determine if acute inflammation affects CNP production in pediatric patients.

Main Methods:

  • Studied 42 acutely ill children (2 months to 5 years) and 15 healthy controls.
  • Measured venous concentrations of NTproCNP and CNP.
  • Assessed inflammatory markers: body temperature, C-reactive protein (CRP), and white blood cell count.

Main Results:

  • Acutely ill children showed significantly suppressed NTproCNP and CNP standard deviation scores (SDSs) compared to controls.
  • NTproCNP SDS was inversely correlated with body temperature (r = -0.42) and CRP levels (r = -0.56).

Conclusions:

  • Acute inflammation in young children markedly reduces CNP production.
  • Reduced CNP during illness must be considered when evaluating growth disorders.
  • Inflammatory cytokines may contribute to impaired skeletal growth via decreased CNP.
Abstract

Related Concept Videos

Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Acute Inflammation II: Local and Systemic Effects01:25

Acute Inflammation II: Local and Systemic Effects

Acute inflammation produces a coordinated set of local and systemic changes that limit injury, eliminate pathogens, and initiate repair. These responses arise within minutes of infection, trauma, or chemical insult and are driven by vascular alterations and leukocyte-derived mediators. When the stimulus resolves, the reaction typically abates within days.Local EffectsAt the site of injury, arteriolar vasodilation increases blood flow, resulting in redness and warmth. Simultaneously, increased...
Inflammatory Response01:28

Inflammatory Response

An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Acute Inflammation I: Inflammatory Response01:26

Acute Inflammation I: Inflammatory Response

Acute inflammation is a rapid, short-lived physiological response to tissue injury or infection, designed to eliminate harmful agents and initiate repair. This tightly regulated process typically lasts from minutes to several days and is triggered by factors such as microbial invasion, physical trauma, or chemical injury.Recognition and Mediator ReleaseThe inflammatory response begins when resident immune cells—such as mast cells, macrophages, and dendritic cells—detect damage-associated...
Inflammatory Response I: Vascular and Cellular01:30

Inflammatory Response I: Vascular and Cellular

The inflammatory response is the body's defense against infection, injury, or irritation from bacteria, trauma, toxins, or heat. Inflammation helps locate and destroy pathogens and remove damaged tissue elements to heal the body. During this initial phase, fluid, blood products, and nutrients migrate to the injured area, resulting in redness, heat, swelling, ache, and loss of function. Moreover, signs of systemic inflammation include fever, increased WBC count, malaise, anorexia, nausea,...
Acute Inflammation I: Cellular Phase01:26

Acute Inflammation I: Cellular Phase

The cellular phase of acute inflammation is a tightly orchestrated sequence of events that recruits leukocytes, primarily neutrophils, to sites of tissue injury or infection. Following the initial vascular changes, this phase ensures effective immune cell migration, activation, and function at the affected site to eliminate pathogens and initiate tissue repair.Leukocyte Recruitment CascadeLeukocyte recruitment happens in four steps: margination, adhesion, transmigration, and chemotaxis. Reduced...